Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

11.13
+0.26002.39%
Post-market: 11.05-0.0800-0.72%18:19 EST
Volume:3.02M
Turnover:33.64M
Market Cap:1.48B
PE:-1.47
High:11.47
Open:11.04
Low:10.89
Close:10.87
52wk High:44.28
52wk Low:7.48
Shares:132.64M
Float Shares:112.00M
Volume Ratio:1.10
T/O Rate:2.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5868
EPS(LYR):-9.2774
ROE:-522.08%
ROA:-106.25%
PB:-86.03
PE(LYR):-1.20

Loading ...

Biohaven Ltd : Raymond James Cuts Target Price to $50 From $54

THOMSON REUTERS
·
Nov 12

Biohaven Ltd: Pricing Offering of 23.3 Mln Shares at $7.50 per Share

THOMSON REUTERS
·
Nov 12

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

THOMSON REUTERS
·
Nov 12

Stock Track | Biohaven Pharmaceutical Plunges 6.46% Pre-market Following $150 Million Share Offering Announcement

Stock Track
·
Nov 12

Stock Track | Biohaven Pharmaceutical Plunges 6.10% Following $150 Million Common Share Offering Announcement

Stock Track
·
Nov 12

Stock Track | Biohaven Pharmaceutical Plunges 6.10% Following $150 Million Common Share Offering Announcement

Stock Track
·
Nov 12

BUZZ-Biohaven slumps after $150 mln stock sale plans announced

Reuters
·
Nov 12

Stock Track | Biohaven Plunges 7.28% After-Hours on $150 Million Common Share Offering Announcement

Stock Track
·
Nov 12

Stock Track | Biohaven Plunges 7.28% After-Hours on $150 Million Common Share Offering Announcement

Stock Track
·
Nov 12

Biohaven Launches $150 Million Offering of Common Shares

MT Newswires Live
·
Nov 12

Stock Track | Biohaven Pharmaceutical Soars 12.58% on $150 Million Public Offering Announcement

Stock Track
·
Nov 12

BRIEF-Biohaven Announces Proposed Public Offering Of Common Shares

Reuters
·
Nov 12

Biohaven Announces Proposed Public Offering of Common Shares

THOMSON REUTERS
·
Nov 12

Biohaven Ltd: Commenced an Underwritten Public Offering of $150 Mln of Its Common Shares

THOMSON REUTERS
·
Nov 12

Biohaven Stock up 2.3% Premarket After Q3 Results

THOMSON REUTERS
·
Nov 10

Biopharma firm Biohaven's Q3 net loss widens to $173.4 mln

Reuters
·
Nov 10

Biohaven Q3 Adj. EPS $(1.47) Beats $(1.73) Estimate

Benzinga
·
Nov 10

Biohaven Reports Q3 Net Loss of $173.4 Million

Reuters
·
Nov 10

Biohaven Q3 Operating Expenses USD 169.382 Million

THOMSON REUTERS
·
Nov 10

Biohaven Q3 Basic EPS USD -1.64

THOMSON REUTERS
·
Nov 10